Mersana Therapeutics Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 101-200 Employees

Mersana Therapeutics revenue & valuation

Annual revenue	$34,800,000
Revenue per employee	$311,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$111,300,000
Total funding	$100,000,000

Key Contact at Mersana Therapeutics

Martin Huber

President & Chief Executive Officer

Mobile @mersana.com

Company overview

Headquarters	840 Memorial Drive, Cambridge, MA 02139, US
Phone number	+16174980020
Website	mersana.com
NAICS	541714
SIC	873
Keywords	Oncology, Drug Development, Cancer Research, Bioconjugation, Antibody Drug Conjugates
Founded	2001
Employees	101-200
Socials

Mersana Therapeutics Email Formats

Mersana Therapeutics uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@mersana.com), used 50% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@mersana.com	50%
{first initial}{last name}	jdoe@mersana.com	46.3%
{first initial}.{last name}	j.doe@mersana.com	1.9%
{last name}{last name}	doedoe@mersana.com	1.9%

About Mersana Therapeutics

At Mersana, we have a passion for advancing therapies to make a significant impact in the lives of people living with cancer. Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are waiting for new treatment options. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms that are generating a pipeline of wholly-owned and partnered product candidates with the potential to treat a range of cancers. Its pipeline includes XMT-1660, a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2).

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Director

Manager

Employees by Department

Mersana Therapeutics has 48 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Mersana Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-02-01	16	$100,000,000

Funding Insights

$100,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

Mersana Therapeutics Tech Stack

Discover the technologies and tools that power Mersana Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Ninja Forms

Form builders

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

PWA

Miscellaneous

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Frequently asked questions

Mersana Therapeutics is located in Cambridge, Massachusetts, US.

You can reach Mersana Therapeutics at +16174980020.

Mersana Therapeutics generates an estimated annual revenue of $34,769,000. This revenue figure reflects the company's market position and business performance in its industry.

Mersana Therapeutics has an estimated valuation of $111,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Mersana Therapeutics was founded in 2001, making it 25 years old. The company has established itself as a significant player in its industry over this time.

Mersana Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Mersana Therapeutics has raised a total of $100,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Mersana Therapeutics

Martin Huber

President & Chief Executive Officer

Mobile @mersana.com

4.8

40,000 users